The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion
Open accessAbstract
Exhausted CD8+ T (T ex) cells in chronic infections and cancer have limited effector function, high co-expression of inhibitory receptors and extensive transcriptional changes compared with effector (T eff) or memory (T mem) CD8+ T cells. T ex cells are important clinical targets of checkpoint blockade and other immunotherapies. Epigenetically, T ex cells are a distinct immune subset, with a unique chromatin landscape compared with T eff and T mem cells. However, the mechanisms that govern the transcriptional and epigenetic development of T ex cells remain unknown. Here we identify the HMG-box transcription factor TOX as a central regulator of T ex cells in mice. TOX is largely dispensable for the formation of T eff and T mem cells, but it is critical for exhaustion: in the absence of TOX, T ex cells do not form. TOX is induced by calcineurin and NFAT2, and operates in a feed-forward loop in which it becomes calcineurin-independent and sustained in T ex cells. Robust expression of TOX therefore results in commitment to T ex cells by translating persistent stimulation into a distinct T ex cell transcriptional and epigenetic developmental program.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“which transcriptionally and epigenetically programs CD8+ T cell exhaustion [52].”
From Single-cell transcriptome reveals the reprogramming of immune microenvironment during the transition from MASH to HCC (2025) · cites this paper as [52]
The cited source says what the claim attributes to it.
In the citing paper
“Treatment‐induced declines in PD‐1+ CD8 T cells are consistent with the possibility that thymus regeneration treatment epigenetically reprograms “exhausted” CD8 T cells (T EX), a recently characterized distinct PD‐1+ CD8 population (Khan et al., 2019).”
From Reversal of epigenetic aging and immunosenescent trends in humans. (2019) · cites this paper as Khan et al., 2019
In the citing paper
“The excessive antigen density and kinetics of antigen exposure in solid tumors can drive exhaustion or dysfunction of T cells (Khan et al., 2019; Wherry, 2011).”
From Pooled Knockin Targeting for Genome Engineering of Cellular Immunotherapies (2020) · cites this paper as Khan et al., 2019
In the citing paper
“Furthermore, bulk RNA-seq analysis of isolated cells (ND naïve, HFHC Tem, HFHC Trm, and RES Trm) revealed that both Trm subsets from HFHC mice and RES mice expressed core signature genes of Trm21–24 with exceptions including Itgae (CD103) and Eomes (Fig. 4d).”
From CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells (2021) · cites this paper as [24]
In the citing paper
“CD8 T cells are typically regarded as a uniform population with cytotoxic function; however, recent studies have highlighted the diversity of the CD8 T-cell population (5)(6)(7)(8)(9).”
From The Next Decade of Immune Checkpoint Therapy (2021) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y., & Greenleaf, W. J. (2013) · Nature Methods · doi:10.1038/nmeth.2688 · Cited by 6,422
Molecular and cellular insights into T cell exhaustion
Wherry, E. J., & Kurachi, M. (2015) · Nature Reviews Immunology · doi:10.1038/nri3862 · Cited by 4,652
Self-citationMaster Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes
Whyte, W. A., Orlando, D. A., Hnisz, D., Abraham, B. J., Lin, C. Y., Kagey, M. H., Rahl, P. B., Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.03.035 · Cited by 4,143
Restoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2005) · Nature · doi:10.1038/nature04444 · Cited by 4,057
Self-citationSuper-enhancers in the control of cell identity and disease
Hnisz, D., Abraham, B. J., Lee, T. I., Lau, A., Saint-André, V., Sigova, A. A., Hoke, H. A., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.09.053 · Cited by 3,662
Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing
Zheng, C., Zheng, L., Yoo, J.-K., Guo, H., Zhang, Y., Guo, X., Kang, B., Hu, R., Huang, J. Y., Zhang, Q., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.035 · Cited by 2,152
Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function
Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J. D., Suresh, M., Altman, J. D., & Ahmed, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2205 · Cited by 1,978
Cited by
Sorted by citations
Items 201–300 of 1,001
Activation of CAR and non-CAR T cells within the tumor microenvironment following CAR T cell therapy
Chen, P.-H., Lipschitz, M., Weirather, J. L., Jacobson, C. A., Armand, P. A., Wright, K., Hodi, F. S., Roberts, Z. J., Sievers, S. A., Rossi, J. M., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.134612 · Cited by 112
Zhou, X., Ni, Y., Liang, X., Lin, Y., An, B., He, X., & Zhao, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.915094 · Cited by 111
Zebley, C. C., Brown, C., Tian, M., Fan, Y., Alli, S., Boi, S. K., Galletti, G., Lugli, E., Langfitt, D. M., Métais, J., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110079 · Cited by 109
Chiang, E. Y., de Almeida, P. E., Nagata, D. D. A., Bowles, K. H., Du, X., Chitre, A. S., Banta, K. L., Kwon, Y. C., McKenzie, B. S., Mittman, S., et al. (2020) · European Journal of Immunology · doi:10.1002/eji.201948405 · Cited by 107
Tissue-resident memory CD8 T cell diversity is spatiotemporally imprinted
Reina‐Campos, M., Monell, A., Ferry, A., Luna, V., Cheung, K. P., Galletti, G., Scharping, N. E., Takehara, K. K., Quon, S., Challita, P. P., et al. (2025) · Nature · doi:10.1038/s41586-024-08466-x · Cited by 111
Wang, Q., Gao, J., Di, W. J., & Wu, X. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02576-x · Cited by 104
LSD1 inhibition sustains T cell invigoration with a durable response to PD-1 blockade
Liu, Y., Debo, B. M., Li, M., Shi, Z., Sheng, W., & Shi, Y. (2021) · Nature Communications · doi:10.1038/s41467-021-27179-7 · Cited by 109
Memory T-Cell Heterogeneity and TerminologyPreprint
Muroyama, Y., & Wherry, E. J. (2021) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a037929 · Cited by 104
Self-citationControl of Lymphocyte Fate, Infection, and Tumor Immunity by TCF-1
Raghu, D., Xue, H., & Mielke, L. A. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.10.006 · Cited by 98
Programme of self-reactive innate-like T cell-mediated cancer immunity
Chou, C., Zhang, X., Krishna, C., Nixon, B. G., Dadi, S., Capistrano, K. J., Kansler, E. R., Steele, M., Han, J., Shyu, A., et al. (2022) · Nature · doi:10.1038/s41586-022-04632-1 · Cited by 99
Rewiring mitochondrial metabolism to counteract exhaustion of CAR-T cells
Huang, Y., Si, X., Shao, M., Teng, X., Xiao, G., & Huang, H. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01255-x · Cited by 110
Integrated Multi-Omics Landscape of Liver Metastases
Yang, S., Qian, L., Li, Z., Li, Y., Bai, J., Zheng, B. J., Chen, K., Qiu, X., Cai, G., Wang, S., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.11.029 · Cited by 106
Self-citationRole of CD4+ T Cells in the Control of Viral Infections: Recent Advances and Open Questions
Kervevan, J., & Chakrabarti, L. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020523 · Cited by 108
Chung, H. K., McDonald, B., & Kaech, S. M. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20201730 · Cited by 105
Intermittent PI3Kδ inhibition sustains anti-tumour immunity and curbs irAEs
Eschweiler, S., Ramírez-Suástegui, C., Li, Y., King, E. V., Chudley, L., Thomas, J., Wood, O., Witzleben, A. V., Jeffrey, D. L., McCann, K. J., et al. (2022) · Nature · doi:10.1038/s41586-022-04685-2 · Cited by 101
Depuydt, M. A. C., Schaftenaar, F. H., Prange, K. H. M., Boltjes, A., Hemme, E., Delfos, L., de Mol, J., de Jong, M. J. M., Kleijn, M. N. A. B., Peeters, J. A. H. M., et al. (2023) · Nature Cardiovascular Research · doi:10.1038/s44161-022-00208-4 · Cited by 105
Cellular and molecular mechanisms of CD8(+) T cell differentiation, dysfunction and exhaustion
Verdon, D. J., Mulazzani, M., & Jenkins, M. R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197357 · Cited by 98
Ozga, A. J., Chow, M. T., Lopes, M. E., Servis, R. L., Pilato, M. D., Dehio, P., Lian, J., Mempel, T. R., & Luster, A. D. (2021) · Immunity · doi:10.1016/j.immuni.2021.11.002 · Cited by 96
SLAMF7 Signaling Reprograms T Cells toward Exhaustion in the Tumor Microenvironment
O’Connell, P., Hyslop, S., Blake, M. K., Godbehere, S., Amalfitano, A., & Aldhamen, Y. A. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000300 · Cited by 97
Xie, F., Zhou, X., Li, H., Su, P., Liu, S., Li, R., Zou, J., Xiang, W. D., Pan, C., Zhang, Z., et al. (2022) · The EMBO Journal · doi:10.15252/embj.2021108791 · Cited by 102
Extremely Differentiated T Cell Subsets Contribute to Tissue Deterioration During Aging
Soto‐Heredero, G., Heras, M. M. G. D. L., Escrig-Larena, J. I., & Mittelbrunn, M. (2023) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101721-064501 · Cited by 96
TCF-1: a maverick in T cell development and function
Gounari, F., & Khazaie, K. (2022) · Nature Immunology · doi:10.1038/s41590-022-01194-2 · Cited by 95
CD8 + T cell exhaustion in anti‐tumour immunity: The new insights for cancer immunotherapy
Huang, Y., Jia, A., Wang, Y., & Liu, G. (2022) · Immunology · doi:10.1111/imm.13588 · Cited by 96
Regulation of CD8+ T memory and exhaustion by the mTOR signals
Chen, Y., Xu, Z., Sun, H., Ouyang, X., Han, Y., Yu, H., Wu, N., Xie, Y., & Su, B. (2023) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-01064-3 · Cited by 101
In vitro modeling of CD8 + T cell exhaustion enables CRISPR screening to reveal a role for BHLHE40
Wu, J. E., Manne, S., Ngiow, S. F., Baxter, A. E., Huang, H., Freilich, E., Clark, M. L., Lee, J. H., Chen, Z., Khan, O., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.ade3369 · Cited by 101
Self-citationSupervised discovery of interpretable gene programs from single-cell data
Kunes, R., Walle, T., Land, M., Nawy, T., & Pe’er, D. (2023) · Nature Biotechnology · doi:10.1038/s41587-023-01940-3 · Cited by 106
Targeting the NF-κB pathway as a potential regulator of immune checkpoints in cancer immunotherapy
Ebrahimi, N., Abdulwahid, A. R. R., Mansouri, A., Karimi, N., Bostani, R. J., Beiranvand, S., Adelian, S., Khorram, R., Vafadar, R., Hamblin, M. R., et al. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-05098-8 · Cited by 101
A liver immune rheostat regulates CD8 T cell immunity in chronic HBV infection
Bosch, M., Kallin, N., Donakonda, S., Zhang, J. D., Wintersteller, H., Hegenbarth, S., Heim, K., Ramirez, C., Fürst, A., Lattouf, E. I., et al. (2024) · Nature · doi:10.1038/s41586-024-07630-7 · Cited by 97
Role of TCF‐1 in differentiation, exhaustion, and memory of CD8 + T cells: A review
Zhang, J., Lyu, T., Cao, Y., & Feng, H. (2021) · The FASEB Journal · doi:10.1096/fj.202002566r · Cited by 109
Reprogramming the tumor microenvironment by genome editing for precision cancer therapy
Liu, K., Cui, J., Zhan, Y., Ouyang, Q., Lu, Q., Yang, D., Li, X., & Yin, J. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01561-5 · Cited by 100
Precursors of exhausted T cells are pre-emptively formed in acute infection
Chu, T., Wu, M., Höllbacher, B., de Almeida, G. P., Wurmser, C., Berner, J., Donhauser, L. V., Gerullis, A.-K., Lin, S., Cepeda-Mayorga, J. D., et al. (2025) · Nature · doi:10.1038/s41586-024-08451-4 · Cited by 101
Efficient CRISPR/Cas9 Gene Editing in Uncultured Naive Mouse T Cells for In Vivo Studies
Nüssing, S., House, I. G., Kearney, C. J., Chen, A. X. Y., Vervoort, S. J., Beavis, P. A., Oliaro, J., Johnstone, R. W., Trapani, J. A., & Parish, I. A. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901396 · Cited by 92
Shan, Q., Hu, S. S., Chen, X., Danahy, D. B., Badovinac, V. P., Zang, C., & Xue, H. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-0436-5 · Cited by 95
Engineering better chimeric antigen receptor T cells
Zhang, H., Zhao, P., & Huang, H. (2020) · Experimental Hematology & Oncology · doi:10.1186/s40164-020-00190-2 · Cited by 93
Chuntova, P., Chow, F. E., Watchmaker, P. B., Galvez, M., Heimberger, A. B., Newell, E. W., Diaz, A. A., DePinho, R. A., Li, M. O., Wherry, E. J., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa277 · Cited by 89
Self-citationShi, Y. X., Zhang, Q., Bi, H., Lu, M., Tan, Y., Zou, D., Ge, L., Chen, Z., Liu, C., Ci, W., et al. (2022) · Genome biology · doi:10.1186/s13059-022-02651-9 · Cited by 94
BCL6 promotes a stem-like CD8 + T cell program in cancer via antagonizing BLIMP1
Sun, Q., Cai, D., Liu, D., Zhao, X., Li, R., Xu, W. M., Xie, B., Gou, M., Wei, K., Li, Y., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.adh1306 · Cited by 94
Self-citationSingle-cell immunology: Past, present, and future
Ginhoux, F., Yalin, A., Dutertre, C., & Amit, I. (2022) · Immunity · doi:10.1016/j.immuni.2022.02.006 · Cited by 96
Guo, X., Nie, H., Zhang, W., Li, J., Ge, J., Xie, B., Hu, W., Zhu, Y., Zhong, N., Zhang, X., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.01.001 · Cited by 100
Reprogramming T cell differentiation and exhaustion in CAR-T cell therapy
Bulliard, Y., Andersson, B. S., Baysal, M. A., Damiano, J. S., & Tsimberidou, A. M. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01504-7 · Cited by 98
Lee, Y.-H., Lee, H. J., Kim, H. C., Lee, Y., Nam, S. K., Hupperetz, C., Ma, J. S. Y., Wang, X., Singer, O., Kim, W. S., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.10.004 · Cited by 89
Li, X., Li, Y., Dong, L., Chang, Y., Zhang, X., Wang, C., Chen, M., Bo, X., Chen, H., Han, W., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci165673 · Cited by 92
Tumor immunogenicity dictates reliance on TCF1 in CD8+ T cells for response to immunotherapy
Escobar, G., Tooley, K., Oliveras, J. P., Huang, L., Cheng, H., Bookstaver, M. L., Edwards, C., Froimchuk, E., Xue, C., Mangani, D., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.08.001 · Cited by 91
Ge, Z., Zhou, G., Carrascosa, L. C., Gausvik, E., Boor, P. P. C., Noordam, L., Doukas, M., Polak, W. G., Terkivatan, T., Pan, Q., et al. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.03.003 · Cited by 90
Sorrentino, C., D’Antonio, L., Fieni, C., Ciummo, S. L., & Carlo, E. D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.778329 · Cited by 92
Transcriptional signatures associated with persisting CD19 CAR-T cells in children with leukemia
Anderson, N. D., Birch, J., Accogli, T., Criado, I., Khabirova, E., Parks, C., Wood, Y., Young, M. D., Porter, T., Richardson, R., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02415-3 · Cited by 87
KLF2 maintains lineage fidelity and suppresses CD8 T cell exhaustion during acute LCMV infection
Fagerberg, E., Attanasio, J., Dien, C., Singh, J., Kessler, E., Abdullah, L., Shen, J., Hunt, B. G., Connolly, K. A., Brouwer, E. D., et al. (2025) · Science · doi:10.1126/science.adn2337 · Cited by 90
Self-citationClonal lineage tracing reveals mechanisms skewing CD8+ T cell fate decisions in chronic infection
Kasmani, M. Y., Zander, R., Chung, H. K., Chen, Y., Khatun, A., Damo, M., Topchyan, P., Johnson, K. E., Levashova, D., Burns, R., et al. (2023) · Journal of Experimental Medicine · doi:10.1084/jem.20220679 · Cited by 87
Yang, B., Li, X., Zhang, W., Fan, J., Zhou, Y., Li, W., Yin, J., Yang, X., Guo, E., Li, X., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100856 · Cited by 84
Bae, J., Liu, L., Moore, C., Hsu, E. J., Zhang, A., Ren, Z., Sun, Z., Wang, X., Zhu, J., Shen, J., et al. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-01024-5 · Cited by 85
Baxter, A. E., Huang, H., Giles, J. R., Chen, Z., Wu, J. E., Drury, S., Tuite-Dalton, K. A., Park, S. L., Torres, L., Simone, B. W., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.05.008 · Cited by 83
Self-citationIm, S. J., Obeng, R. C., Nasti, T. H., McManus, D. T., Kamphorst, A. O., Gunisetty, S., Prokhnevska, N., Carlisle, J. W., Yu, K., Sica, G., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2221985120 · Cited by 88
McCutcheon, S. R., Swartz, A. M., Brown, M. C., Barrera, A., Amador, C. M., Siklenka, K., Humayun, L. L., ter Weele, M. A., Isaacs, J. M., Reddy, T. E., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01554-0 · Cited by 89
Regulators of CD8+ T cell exhaustion
Sun, Q., & Dong, C. (2025) · Nature reviews. Immunology · doi:10.1038/s41577-025-01221-x · Cited by 91
Anagnostou, V., Bruhm, D. C., Niknafs, N., White, J. R., Shao, X. M., Sidhom, J.-W., Stein, J. E., Tsai, H., Wang, H., Belcaid, Z., et al. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100139 · Cited by 87
Cellular and molecular waypoints along the path of T cell exhaustion
Lan, X., Zebley, C. C., & Youngblood, B. (2023) · Science Immunology · doi:10.1126/sciimmunol.adg3868 · Cited by 87
The neuroendocrine transition in prostate cancer is dynamic and dependent on ASCL1
Romero, R., Chu, T., González-Robles, T. J., Smith, P., Xie, Y., Kaur, H., Yoder, S., Zhao, H., Mao, C., Kang, W., et al. (2024) · Nature Cancer · doi:10.1038/s43018-024-00838-6 · Cited by 95
Targeting mitochondria: restoring the antitumor efficacy of exhausted T cells
Yang, M., Zhang, S., Sun, L., Huang, L., Yu, J., Zhang, J.-H., Tian, Y., Han, C., & Ma, J. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02175-9 · Cited by 99
Landscape of Exhausted Virus-Specific CD8 T Cells in Chronic LCMV Infection
Sandu, I., Cerletti, D., Oetiker, N., Borsa, M., Wagen, F., Spadafora, I., Welten, S. P. M., Stolz, U., Oxenius, A., & Claassen, M. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108078 · Cited by 78
TOX defines the degree of CD8+ T cell dysfunction in distinct phases of chronic HBV infection
Heim, K., Binder, B., Sagar, Wieland, D., Hensel, N., Llewellyn‐Lacey, S., Emma Gostick, D., Price, D. A., Emmerich, F., Vingerhoet, H., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-322404 · Cited by 82
Self-citationThe Transcription Factor TCF1 in T Cell Differentiation and Aging
Kim, C., Jin, J., Weyand, C. M., & Goronzy, J. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186497 · Cited by 86
Therapeutic vaccination for treatment of chronic hepatitis B
Cargill, T. N., & Barnes, E. J. (2021) · Clinical & Experimental Immunology · doi:10.1111/cei.13614 · Cited by 87
Hu, Y., Hudson, W. H., Kissick, H. T., Medina, C. B., Baptista, A. P., Ma, C., Liao, W., Germain, R. N., Turley, S. J., Zhang, N., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20211574 · Cited by 86
Architects of immunity: How dendritic cells shape CD8 + T cell fate in cancer
Bhandarkar, V., Dinter, T., & Spranger, S. (2025) · Science Immunology · doi:10.1126/sciimmunol.adf4726 · Cited by 88
Ding, Z., Shi, H., Aboelella, N. S., Fesenkova, K., Park, E.-J., Liu, Z., Pei, L., Li, J., McIndoe, R., Xu, H., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.aba5962 · Cited by 82
IL2 Targeted to CD8+ T Cells Promotes Robust Effector T-cell Responses and Potent Antitumor Immunity
Moynihan, K. D., Kumar, M. P., Sultan, H., Pappas, D. C., Park, T., Chin, S. M., Bessette, P. H., Lan, R. Y., Nguyen, H. C., Mathewson, N. D., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-1266 · Cited by 79
Zhao, M., Kiernan, C. H., Stairiker, C. J., Hope, J. L., León, L. G., van Meurs, M., Brouwers-Haspels, I., Boers, R., Boers, J., Gribnau, J. H., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008555 · Cited by 81
The diversity of CD8+ T cell dysfunction in cancer and viral infection
Galluzzi, L., Smith, K. N., Liston, A., & Garg, A. D. (2025) · Nature reviews. Immunology · doi:10.1038/s41577-025-01161-6 · Cited by 94
Transgelin 2 guards T cell lipid metabolism and antitumour function
Hwang, S., Awasthi, D., Jeong, J., Sandoval, T. A., Chae, C.-S., Ramos, Y., Chen, T., Falco, M. M., Salvagno, C., Emmanuelli, A., et al. (2024) · Nature · doi:10.1038/s41586-024-08071-y · Cited by 83
Simon, S., Voillet, V., Vignard, V., Wu, Z., Dabrowski, C., Jouand, N., Beauvais, T., Khammari, A., Braudeau, C., Josien, R., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001631 · Cited by 79
Han, H. S., Jeong, S., Kim, H., Kim, H., Kim, A. R., Kwon, M., Park, S., Woo, C. G., Kim, H. K., Lee, K. H., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.11.035 · Cited by 82
Immune Aging and Immunotherapy in Cancer
Kaiser, M., Semeraro, M. D., Herrmann, M., Absenger, G., Gerger, A., & Renner, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137016 · Cited by 79
Tonic-signaling chimeric antigen receptors drive human regulatory T cell exhaustion
Lamarche, C., Ward‐Hartstonge, K. A., Tian, M., Lin, D. T. S., Huang, Q. B., Brown, A., Edwards, K., Novakovsky, G., Qi, C. N., Kobor, M. S., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2219086120 · Cited by 87
Sun, J., Esplugues, E., Bort, A., Cardelo, M. P., Ruz‐Maldonado, I., Fernández‐Tussy, P., Wong, C., Wang, H., Ojima, I., Kaczocha, M., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01019-6 · Cited by 79
CD8+ T cell exhaustion in the tumor microenvironment of breast cancer
Xie, H., Xi, X., Lei, T., Liu, H., & Xia, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1507283 · Cited by 79
T cell immunity to hepatitis C virus: Lessons for a prophylactic vaccine
Thimme, R. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.09.022 · Cited by 78
Epigenetic strategies to boost CAR T cell therapy
Akbari, B., Ghahri-Saremi, N., Soltantoyeh, T., Hadjati, J., Ghassemi, S., & Mirzaei, H. R. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.08.003 · Cited by 79
Battistello, E., Hixon, K., Comstock, D. E., Collings, C. K., Chen, X., Rodriguez-Hernaez, J., Lee, S., Cervantes, K. S., Hinkley, M. M., Ntatsoulis, K., et al. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.02.026 · Cited by 78
Tumor-specific cholinergic CD4+ T lymphocytes guide immunosurveillance of hepatocellular carcinoma
Zheng, C., Snow, B. E., Elia, A. J., Nechanitzky, R., Dominguez-Brauer, C., Liu, S., Tong, Y., Cox, M. A., Focaccia, E., Wakeham, A. C., et al. (2023) · Nature Cancer · doi:10.1038/s43018-023-00624-w · Cited by 75
Updates on Immunotherapy and Immune Landscape in Renal Clear Cell Carcinoma
Kim, M., Jin, Z., Kolb, R. H., Borcherding, N. C., Chatzkel, J. A., Falzarano, S. M., & Zhang, W. (2021) · Cancers · doi:10.3390/cancers13225856 · Cited by 80
Gallic acid induces T-helper-1-like T reg cells and strengthens immune checkpoint blockade efficacy
Deng, B., Yang, B., Chen, J., Wang, S., Zhang, W., Guo, Y., Han, Y., Li, H., Dang, Y., Yuan, Y., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-004037 · Cited by 75
Colorectal cancer: Metabolic interactions reshape the tumor microenvironment
Chen, J., Zhu, H., Yin, Y., Jia, S., & Luo, X. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188797 · Cited by 75
Antiangiogenic therapy reverses the immunosuppressive breast cancer microenvironment
Chen, W., Shen, L., Jiang, J., Zhang, L., Zhang, Z., Pan, J., Ni, C., & Chen, Z. (2021) · Biomarker Research · doi:10.1186/s40364-021-00312-w · Cited by 77
Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells
Xie, Y., Xie, F., Zhang, L., Zhou, X., Huang, J., Wang, F., Jin, J., Zhang, L., Zeng, L., & Zhou, F. (2021) · Advanced Science · doi:10.1002/advs.202101672 · Cited by 72
Perspective for Precision Medicine for Tuberculosis
Lange, C. G., Aarnoutse, R. E., Chesov, D., van Crevel, R., Gillespie, S. H., Grobbel, H.-P., Kalsdorf, B., Kontsevaya, I., van Laarhoven, A., Nishiguchi, T., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.566608 · Cited by 70
Vincenti, I., Page, N., Steinbach, K., Yermanos, A., Lemeille, S., Nunez, N., Kreutzfeldt, M., Klimek, B., Di Liberto, G., Egervari, K., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abl6058 · Cited by 70
Carmona, S. J., Siddiqui, I., Bilous, M., Held, W., & Gfeller, D. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1737369 · Cited by 69
Liu, J., Yang, X., Wang, H., Li, Z., Deng, H., Liu, J., Xiong, S., He, J., Guo, C., Wang, W., et al. (2021) · mBio · doi:10.1128/mbio.00085-21 · Cited by 71
Self-citationDynamic chromatin regulatory landscape of human CAR T cell exhaustion
Gennert, D. G., Lynn, R. C., Granja, J. M., Weber, E. W., Mumbach, M. R., Zhao, Y., Duren, Z., Sotillo, E., Greenleaf, W. J., Wong, W. H., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2104758118 · Cited by 70
Tillé, L., Cropp, D., Charmoy, M., Reichenbach, P., Andreatta, M., Wyss, T., Bodley, G., Crespo, I., Nassiri, S., Lourenço, J., et al. (2023) · Nature Immunology · doi:10.1038/s41590-023-01614-x · Cited by 74
Modular pooled discovery of synthetic knockin sequences to program durable cell therapies
Blaeschke, F., Chen, Y. Y., Apathy, R., Dániel, B., Chen, A. Y., Chen, P. A., Sándor, K., Zhang, W., Li, Z., Mowery, C. T., et al. (2023) · Cell · doi:10.1016/j.cell.2023.08.013 · Cited by 71
Chen, X., Zhao, J., Yue, S., Li, Z., Duan, X., Lin, Y., Yang, Y., He, J., Gao, L., Pan, Z., et al. (2024) · Nature Cancer · doi:10.1038/s43018-024-00760-x · Cited by 68
Tick-TOX, it’s time for T cell exhaustion
Mann, T. H., & Kaech, S. M. (2019) · Nature Immunology · doi:10.1038/s41590-019-0478-y · Cited by 70
Exhausted T cells and epigenetic status
Zeng, Z., Wei, F., & Ren, X. (2020) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2020.0338 · Cited by 73
CD8+T cell responsiveness to anti-PD-1 is epigenetically regulated by Suv39h1 in melanomas
Niborski, L. L., Gueguen, P., Ye, M., Thiolat, A., Ramos, R. N., Caudana, P., Denizeau, J., Colombeau, L., Rodriguez, R., Goudot, C., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31504-z · Cited by 70
Rewriting History: Epigenetic Reprogramming of CD8+ T Cell Differentiation to Enhance Immunotherapy
Zebley, C. C., Gottschalk, S. M., & Youngblood, B. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.06.008 · Cited by 71
Virus-specific memory T cell responses unmasked by immune checkpoint blockade cause hepatitis
Hutchinson, J. A., Kronenberg, K., Riquelme, P., Wenzel, J. J., Glehr, G., Schilling, H., Zeman, F., Evert, K., Schmiedel, M., Mickler, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21572-y · Cited by 66
Chen, J., Song, Y., Miao, F., Chen, G., Zhu, Y., Wu, N., Pang, L., Chen, Z., & Chen, X. (2021) · Cancer Science · doi:10.1111/cas.15033 · Cited by 70
Glioblastoma-instructed astrocytes suppress tumour-specific T cell immunity
Akl, C. F., Andersen, B. M., Li, Z., Giovannoni, F., Diebold, M., Sanmarco, L. M., Kilian, M., Fehrenbacher, L., Pernin, F., Rone, J. M., et al. (2025) · The Journal of Immunology · doi:10.1038/s41586-025-08997-x · Cited by 78
T Cell Exhaustion and CAR‐T Immunotherapy in Hematological Malignancies
Tang, L., Zhang, Y., Hu, Y., & Mei, H. (2021) · BioMed Research International · doi:10.1155/2021/6616391 · Cited by 72
Metadata
- Authors
- Khan, O., Giles, J. R., McDonald, S., Manne, S., Ngiow, S. F., Patel, K. P., Werner, M. T., Huang, A. C., Alexander, K. A., Wu, J. E., Attanasio, J., Yan, P., George, S. M., Bengsch, B., Staupe, R. P., Donahue, G., Xu, W., Amaravadi, R. K., Xu, X., Karakousis, G. C., Mitchell, T. C., Schuchter, L. M., Kaye, J., Berger, S. L., & Wherry, E. J.
- Affiliations
- Arsenal Biosciences (United States) (US)
- University of Pennsylvania (US)
- University of Freiburg (DE)
- Abramson Cancer Center (US)
- Cedars-Sinai Medical Center (US)
- Parker Institute for Cancer Immunotherapy (US)
- Corresponding author
- Wherry, E. John
- ORCID
- Khan, Omar
- Giles, Josephine R.
- McDonald, Sierra
- Manne, Sasikanth
- Ngiow, Shin Foong
- Patel, Kunal P.
- Werner, Michael T.
- Huang, Alexander C.
- Alexander, Katherine A.
- Wu, Jennifer E.
- Attanasio, John
- Yan, Patrick
- Bengsch, Bertram
- Staupe, Ryan P.
- Donahue, Greg
- Xu, Wei
- Amaravadi, Ravi K.
- Xu, Xiaowei
- Karakousis, Giorgos C.
- Mitchell, Tara C.
- Schuchter, Lynn M.
- Kaye, Jonathan
- Berger, Shelley L.
- Wherry, E. John
- Venue
- Nature
- Published
- 2019-06-17
- Volume
- 571
- Issue
- 7764
- Pages
- 211-218
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC6713202
- OpenAlex
- W2952815301
- Cited by
- 1,646
- References
- 63
- Citations by year
- 2026: 258 · 2025: 249 · 2024: 234 · 2023: 252 · 2022: 211 · 2021: 235 · 2020: 161 · 2019: 43
- FWCI
- 64.93
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute (R01CA078831, F32CA221010, P30CA010815, P01CA210944)
- National Institute of Allergy and Infectious Diseases (R01AI115712, R01AI054977, R01AI105343, F30AI129263, U19AI117950, U19AI082630, P01AI108545)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- TOX transcription factor, CD8+ T cell exhaustion, chromatin landscape, epigenetic regulation, calcineurin, NFATc1, feed-forward loop, inhibitory receptors, chronic infection, cancer immunotherapy, checkpoint blockade, transcriptional programs
- MeSH terms
- Animals, Epistasis, Genetic, Female, Gene Expression Regulation, Genotype, Immunologic Memory, Male, Mice, Inbred BALB C, Mice, Inbred C57BL, Transcription, Genetic, Homeodomain Proteins, CD8-Positive T-Lymphocytes, Tumor Escape, Calcineurin, Calcium Signaling, Feedback, Physiological, NFATC Transcription Factors, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
